Naphazoline
From Wikipedia, the free encyclopedia
 |
|
|
Naphazoline
|
|
| Systematic (IUPAC) name | |
| 2-(1-naphthylmethyl)-4,5-dihydro-1 H-imidazole | |
| Identifiers | |
| CAS number | |
| ATC code | R01 |
| PubChem | |
| Chemical data | |
| Formula | C14H14N2 |
| Mol. mass | 210.274 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Topical |
Naphazoline (in the hydrochloride form) is the common name for 2-(1-Naphthylmethyl)-2-imidazoline hydrochloride, an α-adrenergic agonist that functions as a decongestant and vasoconstrictor. It commonly used in over-the-counter and prescription eye drops, to eliminate redness and inflammation. It is an active ingredient in Naphcon-A. It has the molecular formula C14H14N2.HCl and a molecular weight of 246.73 g/mol.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
